Skip to content
healthcare.dev

Rexulti

NDC 59148-037, brexpiprazole, tablet, from Otsuka America Pharmaceutical, Inc..

Product NDC
59148-037
Status
Listed
Labeler
Otsuka America Pharmaceutical, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59148-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BREXPIPRAZOLE1 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
59148-037-07591480037071 BLISTER PACK in 1 CARTON (59148-037-07) / 7 TABLET in 1 BLISTER PACK
59148-037-13591480037131 BOTTLE in 1 CARTON (59148-037-13) / 30 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d301358-6291-4ec1-bd87-37b4ad9bd850
  • NADAC price for package 59148003713

    GET /v1/drugs/nadac/59148003713

Use it

Look up 59148-037 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59148-037 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59148-037. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.